NCT05831111 2025-09-30
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT04053283 2025-03-24
STAR
Akamis Bio
Phase 1 Completed
NCT03408587 2023-05-06
CLEVER
Viralytics
Phase 1 Completed
NCT03852511 2022-06-24
FORTITUDE
Akamis Bio
Phase 1 Completed
NCT00541970 2018-08-17
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
GlaxoSmithKline
Phase 1 Completed